BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2417265)

  • 1. Influence of substance P on nociception and stress.
    Oehme P; Hilse H; Görne RC; Hecht K
    Pharmazie; 1985 Aug; 40(8):568-70. PubMed ID: 2417265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutual antagonism between nerve growth factor and substance P N-terminal activity on nociceptive activity in mice.
    Larson AA; Kitto KF
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1345-50. PubMed ID: 9316845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of stress-induced involution of the thymus in rats by substance P (SP1-11) and its N-terminal fragment SP1-4.
    Oehme P; Hecht K; Jumatov J; Repke H; Hilse H; Cordova A
    Pharmazie; 1987 Jan; 42(1):34-6. PubMed ID: 2437598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of substance P and substance P fragments on the pain threshold in mice].
    Görne RC; Morgenstern E; Oehme P; Bienert M; Neubert K
    Pharmazie; 1982 Apr; 37(4):299-300. PubMed ID: 6179105
    [No Abstract]   [Full Text] [Related]  

  • 5. [Basic trends in research on substance P (a review)].
    Oehme P
    Patol Fiziol Eksp Ter; 1984; (3):57-9. PubMed ID: 6206457
    [No Abstract]   [Full Text] [Related]  

  • 6. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.
    Kreeger JS; Larson AA
    J Pharmacol Exp Ther; 1996 Nov; 279(2):662-7. PubMed ID: 8930169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of substance P to catecholamines, stress, and hypertension.
    Oehme P; Hecht K; Faulhaber HD; Nieber K; Roske I; Rathsack R
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S109-11. PubMed ID: 2455160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An antinociceptive effect of capsaicin in the adult mouse mediated by the NH2-terminus of substance P.
    Mousseau DD; Sun X; Larson AA
    J Pharmacol Exp Ther; 1994 Feb; 268(2):785-90. PubMed ID: 7509392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsensitivity to substance P in SART-stressed mice.
    Hata T; Itoh E; Oyama R; Kawabata A; Kita T
    Jpn J Pharmacol; 1989 Feb; 49(2):293-6. PubMed ID: 2471860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status and developments in substance P research (selected topics).
    Oehme P; Hecht K
    Pharmazie; 1984 Feb; 39(2):121-2. PubMed ID: 6201930
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute effects of intrathecal capsaicin and substance P on nociceptive thresholds in rats].
    Dib B
    C R Seances Acad Sci III; 1983; 296(20):969-74. PubMed ID: 6193849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetyl beta-endorphin-(1-31) and substance P regulate the supraspinal antinociception mediated by mu opioid and alpha-2 adrenoceptors but not by delta opioid receptors in the mouse.
    Sánchez-Blázquez P; Garzón J
    J Pharmacol Exp Ther; 1993 May; 265(2):835-43. PubMed ID: 7684446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception.
    Patte-Mensah C; Kibaly C; Mensah-Nyagan AG
    Proc Natl Acad Sci U S A; 2005 Jun; 102(25):9044-9. PubMed ID: 15951421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal substance P augments morphine-induced antinociception: possible relevance in the production of substance P N-terminal fragments.
    Komatsu T; Sasaki M; Sanai K; Kuwahata H; Sakurada C; Tsuzuki M; Iwata Y; Sakurada S; Sakurada T
    Peptides; 2009 Sep; 30(9):1689-96. PubMed ID: 19520130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of substance P to catecholamine metabolism and stress.
    Oehme P
    Biomed Biochim Acta; 1985; 44(10):1401-9. PubMed ID: 2417591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurochemical analysis and pharmacological regulation of the corticofugal control of the nociceptive signals in the afferent pathways].
    Churiukanov VV
    Eksp Klin Farmakol; 2003; 66(2):24-31. PubMed ID: 12962044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of substance P and substance P--sequences on immunocompetent cells.
    Paegelow I; Werner H; Bienert M; Oehme P
    Pharmazie; 1989 Feb; 44(2):145-6. PubMed ID: 2473479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the substance P-induced anti-nociception in the central nervous system of rats after morphine tolerance.
    Dong XG; Yu LC
    Neurosci Lett; 2005 Jun 10-17; 381(1-2):47-50. PubMed ID: 15882788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P potentiates thermal hyperalgesia induced by intrathecal administration of D-serine in rats.
    Zhang YH; Shu YS; Zhao ZQ
    Acta Pharmacol Sin; 2001 Sep; 22(9):817-20. PubMed ID: 11749863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small peptides mimicking substance P (1-7) and encompassing a C-terminal amide functionality.
    Fransson R; Botros M; Nyberg F; Lindeberg G; Sandström A; Hallberg M
    Neuropeptides; 2008 Feb; 42(1):31-7. PubMed ID: 18093649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.